Table 3 CMV- and EBV- derived peptides used for stimulation of T cells
| Â | Abbr. | Full sequence | -mer | Protein | HLA restriction | References |
|---|---|---|---|---|---|---|
CMV no. | ||||||
 1 | VTE | VTEHDTLLY | 9 | pp50 | A*01:01 | Elkington et al. [41] |
 2 | YSE | YSEHPTFTSQY | 11 | pp65 | A*01:01 | Longmate et al. [42] |
 3 | NLV | NLVPMVATV | 9 | pp65 | A*02:01 | Diamond et al. [43] |
 4 | VLE | VLEETSVML | 9 | IE-1 | A*02:01 | Khan et al. [44] |
 5 | TPR | TPRVTGGGAM | 10 | pp65 | B*07:02 | Weekes et al. [45] |
 6 | RPH | RPHERNGFTVL | 11 | pp65 | B*07:02 | Weekes et al. [45] |
 7 | ELK | ELKRKMMYM | 9 | IE-1 | B*08:01 | Elkington et al. [41] |
 8 | QIK | QIKVRVDMV | 9 | IE-1 | B*08:01 | Elkington et al. [41] |
 9 | IPS | IPSINVHHY | 9 | pp65 | B*35:01 | Gavin et al. [46] |
 10 | CRV | CRVLCCYVL | 9 | IE-1 | C*07:02 | Ameres et al. [21] |
 11 | KYQE | KYQEFFWDANDIYRI | 15 | pp65 | DR1, DR3 | Wiesner et al. [47] |
 12 | EHPT | EHPTFTSQYRIQGKL | 15 | pp65 | DR11 | Kern et al. [48] |
 13 | AGIL | AGILARNLVPMVATV | 15 | pp65 | DRB3, DRB5 | Wiesner et al. [47] |
 14 | MSIY | MSIYVYALPLKMLNI | 15 | pp65 | DR15 | Wiesner et al. [47] |
 15 | EFFT | EFFTKNSAFPKTT | 13 | IE-1 | DRB5*01:01 | Ameres et al. [49] |
 16 | KVYL | KVYLESFCEDVPSGK | 15 | pp65 | DR11 | Moosmann et al. unpublished |
 17 | SVMK | SVMKRRIEEICMKVF | 15 | IE-1 | DP3, 20, 14 | Ameres et al. [49] |
EBV no. | ||||||
 1 | CLG | CLGGLLTMV | 9 | LMP2 | A*02:01 | Lee et al. [50] |
 2 | GLC | GLCTLVAML | 9 | BMLF1 | A*02:01 | Steven et al. [51] |
 3 | YVL | YVLDHLIVV | 9 | BRLF1 | A*02:01 | Saulquin et al. [52] |
 4 | FLY | FLYALALLL | 9 | LMP2 | A*02:01 | Meij et al. [53] |
 5 | RPP | RPPIFIRRL | 9 | EBNA3A | B*07:02 | Hill et al. [54] |
 6 | QAK | QAKWRLQTL | 9 | EBNA3A | B*08:01 | Burrows et al. [55] |
 7 | RAK | RAKFKQLL | 8 | BZLF1 | B*08:01 | Bogedain et al. [56] |
 8 | YPL | YPLHEQHGM | 9 | EBNA3A | B*35:01 | Burrows et al. [55] |
 9 | HPV | HPVGEADYFEY | 11 | EBNA1 | B*35:01 | Rickinson et al. [57] |
 10 | EPL | EPLPQGQLTAY | 11 | BZLF1 | B*35:01 | Saulquin et al. [52] |
 11 | PYYV | PYYVVDLSVRGM | 12 | BHRF1 | DR4 | Landais et al. [58] |
 12 | VVRM | VVRMFMRERQLPQS | 14 | EBNA3C | DR11 | Leen et al. [59] |
 13 | FGQL | FGQLTPHTKAVYQPR | 15 | BLLF1 | DR13 | Adhikary et al. [60] |
 14 | IPQC | IPQCRLTPLSRLPFG | 15 | EBNA1 | DR13 | Mautner et al. [61] |
 15 | TDAW | TDAWRFAMNYPRNPT | 15 | BNRF1 | DR15 | Milosevic et al. [62] |
 16 | VSDY | VSDYGYNEALAV | 12 | BNRF1 | DRB3*02:02 | Mautner et al. unpublished |
 17 | AIQY | AIQYVRFLETA | 11 | BcLF1 | DPB1*04:01 | Mautner et al. unpublished |